Here’s what you should know:
1. The company will aim to create emerging market-facing global endoscopy solutions.
2. The company is targeting the flexible endoscopy market for its growth potential. In a release, the company claims the market is currently valued at $2.5 billion, growing at a compound annual growth rate of 5 percent.
3. The company will be headquartered in Asia and will distribute products in Asia, Latin America, Eastern Europe, the Middle East and Africa.
More articles on gastroenterology:
Effector, Pfizer, Merck partner to test novel immuno-oncology agents in CRC — 4 key notes
GI center to know: Gastroenterology Consultants of Southwest Virginia
Sucampo Pharmaceuticals aims to grow Amitiza line — 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
